Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Cardiomyopathy, Hypertrophic

• An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM
• A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy
• Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM
• A Trial of HRS-1893 in Healthy Volunteers and Patients With Obstructive Hypertrophic Cardiomyopathy
• The Purpose of This Study is to Compare the Efficacy and Safety of Aficamten (CK-3773274) Compared With Metoprolol Succinate in Adults With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction
• A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy
• Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy
• A Study to Evaluate the Efficacy, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy
• Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia
• A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy
• Lifestyle and Pharmacological Interventions in Hypertrophic Cardiomyopathy
• CY 6031 Study Will Evaluate the Effects of Treatment With Aficamten (CK-3773274) Over a 24-week Period on Cardiopulmonary Exercise Capacity and Health Status in Patients With Symptomatic oHCM
• Empagliflozin in Hypertrophic Cardiomyopathy
• A Study to Evaluate the Efficacy and Safety of Mavacamten in Chinese Adults With Symptomatic Obstructive HCM
• Study Evaluating the Pharmacokinetics of Mavacamten in Healthy Adult Chinese Subjects
• Esmolol for Myocardial Protection in Hypertrophic Obstructive Cardiomyopathy
• Quantitative Assessment of Hypertrophic Obstructive Cardiomyopathy With Intraoperative Three-dimensional Transesophageal Echocardiography Under Provocative Dobutamine Stress Test
• Comparison of Squat-to-Stand Maneuver With Amyl Nitrite, Valsalva, and Exercise Stress Echocardiography in Inducing Latent Left Ventricular Outflow Obstruction in Hypertrophic Cardiomyopathy
• CY 6022 is an Open Label Study to Collect Long-term Safety and Tolerability Data for CK-3773274
• A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy Trial
• Safety, Tolerability and Pharmacokinetics Study of CK-3773274
• The Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy
• Role of Perhexiline in Hypertrophic Cardiomyopathy
• A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic Cardiomyopathy
• A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy
• REDWOOD-HCM: Randomized Evaluation of Dosing With CK-3773274 in Obstructive Outflow Disease in HCM
• Study of Efficacy of Oral Sacubitril/Valsartan in Adult Patients With Non-obstructive Hypertrophic Cardiomyopathy
• Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy
• Effects of Ranolazine on Coronary Microvascular Dysfunction in Patients With Hypertrophic Cardiomyopathy
• Sacubitril/Valsartan vs Lifestyle in Hypertrophic Cardiomyopathy
• A Single and Multiple Ascending Dose Study of CK-3773274 in Healthy Adult Subjects
• A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM
• The Effect of Metoprolol in Patients With Hypertrophic Obstructive Cardiomyopathy.
• Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Previously Enrolled in PIONEER
• Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
• A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)
• Nitrite in Hypertrophic Cardiomyopathy (HCM) Study
• Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve
• Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy
• Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure
• A Phase 2 Open-label Pilot Study Evaluating MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction
• Mobilization of Endothelial Progenitor Cells and Aspirin
• Hypertrophic Cardiomyopathy Symptom Release by BX1514M
• Perfusion Imaging With Myocardial Contrast Echocardiography in HCM
• Efficacy, Safety, and Tolerability of Perhexiline in Subjects With Hypertrophic Cardiomyopathy and Heart Failure
• Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
• Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
• Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
• Ranolazine for the Treatment of Chest Pain in HCM Patients
• Trimetazidine Therapy in Hypertrophic Cardiomyopathy
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEK162 in Noonan Syndrome Hypertrophic Cardiomyopathy
• Hypertrophic Regression With N-Acetylcysteine in HCM
• Compassionate Use of Triheptanoin (C7) for Inherited Disorders of Energy Metabolism
• Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy
• Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy
• Clinical and Therapeutic Implications of Fibrosis in Hypertrophic Cardiomyopathy
• Antiarrhythmic Therapy Versus Catheter Ablation for Atrial Fibrillation in Hypertrophic Cardiomyopathy
• Perhexiline Therapy in Patients With Hypertrophic Cardiomyopathy
• CHANCE - Candesartan in Hypertrophic Cardiomyopathy
• Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem
• Study to Determine if Atorvastatin Reduces Size and Stiffness of Muscle in the Left Ventricle of the Heart
• Pirfenidone to Treat Hypertrophic Cardiomyopathy
• Cyclosporine A to Treat Hypertrophic Cardiomyopathy (HCM)
• Long Term Effects of Enalapril and Losartan on Genetic Heart Disease